Abstract: . . .  Angina Pectoris : Management Strategies Graboys & Blatt Professional Communications, Inc. Page 122 240 Ventriculography, using radionuclide indications for, 63 parameters of, 62 Verapamil (Isoptin, Verelan) adverse effects of, 104 for atrial fibrillation, 178 -blocker interaction with, 98 contraindications to, 103 dosage of, 101t, 103-104, 206 in combination therapy, 110 intravenous, 103-104 nifedipine with, 105 pharmacokinetics of, 98-99, 101t for Prinzmetal s variant angina , 103 tissue selectivity of, 101t Verelan. See Verapamil (Isoptin, Verelan) . Veterans Administration Randomized Trial, 166 Visken. See Pindolol (Visken). Vitamins C and E adverse effects of, 115 dosage of, 115, 123 plaque rupture and, 28 prophylactic, 17 Walking, provocation by, 40, 43 Walnuts, dietary, 136 Warfarin, antioxidants and, 115 Water intake, for weight loss, 137 Wolff-Parkinson-White syndrome, diltiazem in, 103 Women affective disorders in, 193 aspirin effectiveness in, 193-195 cardiac mortality in, 191, 195 chest pain in, 191-192, 204 coexisting disorders in, 191, 195, 205 drug metabolism in, 193 exercise treadmill testing in, 192-193, 195 invasive management of angina in, 193-195 Xanax (alprazolam), dosage, pharmacokinetics, and side effects of, 121t Xanthelasma, 41 Zestril (lisinopril), dosage and pharmacokinetics of, 118t  . . .
--3000,1,1500,1664,48498